Research

Sanders-Brown Researcher Receives Grant Supported by Rotary Clubs to Further Dementia Studies

Dr. Maj-Linda Selenica, assistant professor at the University of Kentucky's Sanders-Brown Center on Aging.
Dr. Maj-Linda Selenica, assistant professor at the University of Kentucky's Sanders-Brown Center on Aging.

LEXINGTON, Ky. (July 8, 2020) - A grant recently received by Maj-Linda B. Selenica, assistant professor at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA), is helping further collaborative research efforts. The $125,000 grant comes from The CART Fund. CART (Coins for Alzheimer’s Research Trust) is a grassroots effort by Rotary Club members throughout the country to provide cutting edge research to help find a cure for Alzheimer’s. Since its inception, CART has awarded more than $9 million in research grants to some of the most respected institutions in the country.

“CART funding is truly meaningful to our laboratory and personally as a researcher. Historically, this grant has been given to promising scientists in the Alzheimer’s disease (AD) field and has been the precursor for bigger discoveries. Further, as I had the chance to present my research for the CART Rotary trust, I realized that rotary clubs consists of dedicated members that strongly care about cutting edge discoveries in AD that can lead to a cure for this devastating disease,” explained Selenica.

Researchers at SBCoA have been the recipients of this funding twice before. “It is a great honor to carry the torch. The fact that this year's funds were trusted in our research is telling of the role that SBCoA has played in the AD research community. I am certain it will provide the seed for extramural funding and new strategies for AD,” said Selenica.

Her lab plans to look at the role of the PAD4 enzyme in modification of tau. Tau is a protein that Selenica says is one of the major culprits in the pathology of AD. This specific investigation plays into other ongoing research that Selenica is collaborating with colleagues (D. Lee, co-Investigator) within SBCoA.

Selenica’s lab discovered that the enzyme they are looking at is involved in TDP-43 protein pathologies. “The TDP-43 protein is widely studied in the ALS/FTD/AD spectrum of diseases and was recently discovered by our very own Dr. Peter Nelson and colleagues, to be the single pathology associated with LATE. For our future studies, we intend to expand our knowledge to TDP-43 pathology in diseases such as AD and LATE.”

 

The University of Kentucky is increasingly the first choice for students, faculty and staff to pursue their passions and their professional goals. In the last two years, Forbes has named UK among the best employers for diversity, and INSIGHT into Diversity recognized us as a Diversity Champion three years running. UK is ranked among the top 30 campuses in the nation for LGBTQ* inclusion and safety. UK has been judged a “Great College to Work for" two years in a row, and UK is among only 22 universities in the country on Forbes' list of "America's Best Employers."  We are ranked among the top 10 percent of public institutions for research expenditures — a tangible symbol of our breadth and depth as a university focused on discovery that changes lives and communities. And our patients know and appreciate the fact that UK HealthCare has been named the state’s top hospital for four straight years. Accolades and honors are great. But they are more important for what they represent: the idea that creating a community of belonging and commitment to excellence is how we honor our mission to be not simply the University of Kentucky, but the University for Kentucky.